Latest filing published 26 Apr 2021 for Lixte Biotechnology Holdings, INC., €27k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephen J. Forman: trading record in brief
Stephen J. Forman discloses dealings in Lixte Biotechnology Holdings, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 7 December 2018 to 22 April 2021.
Every open-market trade on record is a purchase: 2 purchases worth €127k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise.
The latest filing, published on 26 April 2021, reports an option exercise of €27k in Lixte Biotechnology Holdings, Inc. The last insider purchase was made public on 3 December 2020, 2,167 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen J. Forman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,334 shares@ US$0.9617.3% of flowCommon StockSEC:0001493152-21-009690:0
- 21,053 shares@ US$4.75100.0% of flowCommon StockSEC:0001493152-20-022866:0Canonical exit: 28 Feb 2021 (T+90)
- 100,000 shares@ US$0.5034.5% of flowCommon StockSEC:0001250853-18-000151:0Canonical exit: 7 Mar 2019 (T+90)
3 of 3 declarations
